Development of a rat central venous catheter model for evaluation of vaccines to prevent Staphylococcus epidermidis and Staphylococcus aureus early biofilms

Human Vaccines

Volumn 7, Issue 6, 2011, Pages 630-638

  Ebert, Tim ^a   Smith, Sharon ^a   Pancari, Greg ^a   Wu, Xiaoqing ^a,c   Zorman, Julie ^a   Clark, Desmond ^a   Cook, James C ^a   Burns, Carol ^a   Antonello, Joseph M ^a   Cope, Leslie ^a   Nagy, Eszter ^b   Meinke, Andreas ^b   McNeely, Tessie ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INTERCELL AG   (Austria)

^c Data Virtuoso Inc   (United States)

Author keywords

Antibodies; Biofilm; Immune response; Indwelling catheter; Staphylococcus; Vaccine

Indexed keywords

2 SUCCINYL 6 HYDROXY 2,4 CYCLOHEXADIENE 1 CARBOXYLATE SYNTHASE; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79959326638     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.6.15407     Document Type: Article

References (46)

1. Safdar N, Fine JP, Maki DG. Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005; 142:451-66. (Pubitemid 40365432)
2. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular Trends in Nosocomial Primary Blood-Stream Infections in the United-States, 1980-1989. Am J Med 1991; 91:86-9.
3. Mcgee DC, Gould MK. Current concepts - Preventing complications of central venous catheterization. New Eng J Med 2003; 348:1123-33. (Pubitemid 36337324)
4. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. Guidelines for the management of intravascular catheter: Related infections. Clin Infect Dis 2001; 32:1249-72. (Pubitemid 32405897)
5. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units 1997-2007. JAMA 2009; 301:727-36.
6. Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39:1278-86. (Pubitemid 34591946)
7. O'Grady NP, Alexander M, Dellinger P, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 2002; 110.
8. Elliott TSJ. An update on antimicrobial central venous catheters. J Hos Infect 2007; 65:34-8. (Pubitemid 46805836)
9. Donelli G. Vascular catheter-related infection and sepsis. Surg Infect (Larchmt) 2006; 7:25-7.
10. Morales M, Mendez-Alvarez S, Martin-Lopez JV, Marrero C, Freytes C. Biofilm: the microbial "bunker" for intravascular catheter-related infection. Supportive Care Cancer 2004; 12:701-7.
11. Hammarskjold F, Wallen G, Malmvall BE. Central venous catheter infections at a county hospital in Sweden: a prospective analysis of colonization, incidence of infection and risk factors. Acta Anaesthesiol Scand 2006; 50:451-60.
12. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention and management. Lancet Infect Dis 2007; 7:645-57. (Pubitemid 47444563)
13. Visai L, Arciola CR, Pietrocola G, Rindi S, Oliver P, Speziale P. Staphylococcus biofilm components as targets for vaccines and drugs. Int J of Artif Organs 2007; 30:813-9. (Pubitemid 350081644)
14. Fux CA, Wilson S, Stoodley P. Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriology 2004; 186:4486-91.
15. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009; 11:1034-43.
16. Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol Lett 2004; 236:163-73.
17. Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J of Antimicro Ag 2008; 32:71-8.
18. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, et al. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin and Diagn Lab Immunol 2005; 12:387-98.
19. Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, et al. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 2006; 74:2215-23.
20. Ebert T, Smith S, Pancari G, Clark D, Hampton R, Secore S, et al. A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Hum Antibodies 2010; 19:1-17.
21. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. PNAS 2006; 103:16942-7.
22. Brown M, Kowalski R, Zorman J, Wang XM, Towne V, Zhao QJ, et al. Selection and Characterization of Murine Monoclonal Antibodies to Staphylococcus aureus Iron-Regulated Surface Determinant B with Functional Activity In Vitro and In Vivo. Clin Vac Immunol 2009; 16:1095-104.
23. Kim HK, DeDent A, Cheng AG, McAdow M, Bagnoli F, Missiakas DM, Schneewind O. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge 2010; 28:6382-92.
24. Sieminska EAL, Macova A, Palmer DRJ, Sanders DAR. Crystallization and preliminary X-ray analysis of (1R, 6R)-2-succinyl-6-hydroxy-2,4-cyclohexadiene- 1-carboxylate (SHCHC) synthase (MenD) from Escherichia coli. Acta Crystallogr F 2005; 61:489-92. (Pubitemid 44210869)
25. Bentley R, Meganathan R. Biosynthesis of Vitamin-K (Menaquinone) in Bacteria. Microbiol Rev 1982; 46:241-80.
26. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, Smeltzer MS, Bayles KW. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 2007; 104:8113-8. (Pubitemid 47185884)
27. Etz H, Minh DB, Henics T, Dryla A, Winkler B, Triska C, et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002; 99:6573-8. (Pubitemid 34526174)
28. Lewis K. Riddle of biofilm resistance. Antimicrob Agents and Chemother 2001; 45:999-1007. (Pubitemid 32230975)
29. Rani SA, Pitts B, Beyenal H, Veluchamy RA, Lewandowski Z, Davison WM, et al. Spatial patterns of DNA replication, protein synthesis and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol 2007; 189:4223-33. (Pubitemid 46847371)
30. Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996; 157:2514-20. (Pubitemid 126450464)
31. Rupp ME, Fey PD, Heilmann C, Gotz F. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. Journal of Infect Dis 2001; 183:1038-42.
32. Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PWM, Van Eldere J. Inhibition of Staphylococcus epidermidis Biofilm Formation by Rabbit Polyclonal Antibodies against the SesC Protein. Infect Immun 2009; 77:3670-8.
33. Gilsdorf JR, Wilson K, Beals TF. Bacterial-Colonization of Intravenous Catheter Materials In vitro and In vivo. Surgery 1989; 106:37-44. (Pubitemid 19186186)
34. Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, Laufs R. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: Purification and structural analysis. J Bacteriol 1996; 178:175-83.
35. Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002; 43:1367-78. (Pubitemid 34595531)
36. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67:5427-33.
37. Knobloch JKM, Horstkotte MA, Rohde H, Mack D. Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Med Microbiol Immunol 2002; 191:101-6. (Pubitemid 35193365)
38. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 2002; 70:4987-96.
39. de Silva GDI, Kantzanou M, Justice A, Massey RC, Wilkinson AR, Day NPJ, Peacock SJ. The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol 2002; 40:382-8. (Pubitemid 34130857)
40. O'Gara JP. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 2007; 270:179-88.
41. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 2010; 120:1762-73.
42. Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 2003; 299:906-9.
43. Goldenbaum PE, Keyser PD, White DC. Role of Vitamin-K2 in Organization and Function of Staphylococcus-Aureus Membranes. J Bacteriol 1975; 121:442-9.
44. Acar JF, Goldstein FW, Lagrange P. Human Infections Caused by Thiamine-Requiring Or Menadione-Requiring Staphylococcus-Aureus. J Clin Microbiol 1978; 8:142-7. (Pubitemid 9001350)
45. Bates DM, von Eiff C, McNamara PJ, Peters G, Yeaman MR, Bayer AS, Proctor RA. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J Infect Dis 2003; 187:1654-61.
46. Joyce JG, Abeygunawardana C, Xu QW, Cook JC, Hepler R, Przysiecki CT, et al. Isolation, structural characterization and immunological evaluation of a highmolecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr Res 2003; 338:903-22. (Pubitemid 36398009)